Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Item No. 24995

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Thrombin receptor peptide ligand is antagonist of the thrombin receptor (EC50s = 16-33 µM to inhibit platelet aggregation in vitro).1 It inhibits α-thrombin and platelet aggregation induced by thrombin receptor activating peptide (TRAP; Item No. 24125) in vitro when used at a concentration of 32 µM but does not affect platelet aggregation induced by ADP or collagen. It also inhibits thrombin- and TRAP-induced proliferation of vascular smooth muscle cells (VSMCs).2 Thrombin receptor peptide ligand (100 µmol/kg bolus, i.v., plus 900 µmol/kg infusion) inhibits arterial thrombosis in a rabbit model of partial carotid artery occlusion without increasing bleeding time.3
WARNING This product is not for human or veterinary use.
1. A peptide ligand of the human thrombin receptor antagonizes thrombin receptor activating peptide and α-
2. A peptide analogue of thrombin receptor-
3. Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor. Thromb. Res. 100(1), 89-96 (20000).